Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BZF-29

K-Number: K200682 · 2020-10-02

Decision Date2020-10-02
Product CodeKLE
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

BZF-29 is a medical device manufactured by GC America, Inc.. It received FDA 510(k) clearance on 2020-10-02 under approval number K200682. The device is classified under product code KLE. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BZF-29?

BZF-29 is a medical device that received FDA 510(k) clearance on 2020-10-02. It is manufactured by GC America, Inc.. The 510(k) number is K200682.

When was BZF-29 approved by the FDA?

BZF-29 received FDA 510(k) clearance on 2020-10-02, under approval number K200682.

What company makes BZF-29?

BZF-29 is manufactured by GC America, Inc..

What is the FDA product code for BZF-29?

The FDA product code for BZF-29 is KLE.

Other Devices by GC America, Inc.

View all 21 devices →

Related Devices (Code: KLE)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.